title: Associations of serum alkaline phosphatase with metabolic syndrome and mortality.
abstract: BACKGROUND
  Recent data suggest that elevated serum alkaline phosphatase levels are associated with increased mortality, but the mechanisms for this association are unknown. As metabolic syndrome is associated with higher serum alkaline phosphatase levels, we examined the joint association of mortality with metabolic syndrome and serum alkaline phosphatase levels in the US general population.
  
  
  METHODS
  Retrospective observational study of 15,234 adult participants in the National Health and Nutrition Examination Survey III. Multivariable Cox regression analyses were used to jointly relate mortality risk to serum alkaline phosphatase and indicators of metabolic syndrome.
  
  
  RESULTS
  Prevalence of metabolic syndrome was 14% to 41% among patients in lowest and higher quartiles, respectively, for baseline serum alkaline phosphatase. The mortality hazard ratio for each doubling of serum alkaline phosphatase was 1.52 (95% confidence interval [CI], 1.35-1.72) adjusting only for demographic factors, and 1.37 (95% CI, 1.21-1.56) adjusting for both demographic and metabolic syndrome factors in the full cohort, and was 1.83 (95% CI, 1.36-2.46) adjusting for demographic factors in the subgroup without any of the component conditions of metabolic syndrome.
  
  
  CONCLUSIONS
  In the US general population, higher levels of serum alkaline phosphatase is a predictor of mortality independent of the baseline prevalence of metabolic syndrome. Further studies are warranted to unravel the mechanisms of this association.
authors: VA Salt Lake City Health Care System, Utah, USA.
authors: Vidya Raj
authors: VR
authors: Krishnamurthy
authors: Bradley C
authors: BC
authors: Baird
authors: Guo
authors: G
authors: Wei
authors: Tom
authors: T
authors: Greene
authors: Kalani
authors: K
authors: Raphael
authors: Srinivasan
authors: S
authors: Beddhu
references: J Urol. 2008 Jan;179(1):117-22; discussion 122-3
references: 17997442
references: Atherosclerosis. 2007 Aug;193(2):241-4
references: 17606264
references: Am J Transplant. 2010 Jan;10(1):106-14
references: 19951280
references: Clin J Am Soc Nephrol. 2007 Nov;2(6):1241-8
references: 17928470
references: J Clin Endocrinol Metab. 2006 Dec;91(12):4753-61
references: 16968800
references: N Engl J Med. 2000 Apr 27;342(17):1266-71
references: 10781624
references: Postgrad Med J. 2003 Jun;79(932):307-12
references: 12840117
references: Vital Health Stat 1. 1994 Jul;(32):1-407
references: 7975354
references: Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):193-7
references: 15499043
references: Genes Dev. 1998 May 1;12(9):1260-8
references: 9573043
references: Diabetes. 2005 Nov;54(11):3140-7
references: 16249437
references: Dig Dis Sci. 2006 May;51(5):877-84
references: 16758309
references: J Clin Gastroenterol. 2006 Aug;40(7):633-5
references: 16917408
references: Nephrol Dial Transplant. 2008 Nov;23(11):3670-6
references: 18579534
references: JAMA. 2002 Jan 16;287(3):356-9
references: 11790215
references: J Ren Nutr. 2007 Jan;17(1):38-44
references: 17198930
references: Kidney Int. 2008 Sep;74(5):655-63
references: 18547993
references: Circulation. 2007 Jul 31;116(5):480-8
references: 17646581
references: Circulation. 2009 Nov 3;120(18):1784-92
references: 19841303
references: Int J Epidemiol. 2002 Feb;31(1):163-5
references: 11914314
references: Kidney Int. 2008 May;73(9):1024-30
references: 18288101
references: J Urol. 2009 Feb;181(2):512-6; discussion 516-7
references: 19100570
references: JAMA. 2001 May 16;285(19):2486-97
references: 11368702
references: Am J Kidney Dis. 2006 Jul;48(1):59-68
references: 16797387
references: Clin J Am Soc Nephrol. 2009 Nov;4(11):1805-10
references: 19729429
references: J Am Soc Nephrol. 2008 Nov;19(11):2193-203
references: 18667733